SIM
PDLI

Sonora Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Sonora Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-273
Closed -$1K – 1324
2015
Q3 		$1K Buy
+273
New +$1.56K ﹤0.01% 1074

Other funds holding PDLI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sonora Investment Management's PDLI Position: Q4 2015 in Review

Sonora Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 273 shares — an estimated $1K sold.

Sonora Investment Management first reported a position in PDLI in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

  • Sonora Investment Management reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • Sonora Investment Management sold 273 PDL BioPharma, Inc. shares in Q4 2015, an estimated $1K.
  • Sonora Investment Management first reported a position in PDL BioPharma, Inc. in Q3 2015 and held it in 1 quarter.
  • Sonora Investment Management's PDL BioPharma, Inc. position peaked at $1K in Q3 2015.
  • 204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Sonora Investment Management's 13F filing for Q4 2015, filed 10 Mar 2016.